These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 27645338)
1. Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis. Wang L; Hu W; Wang J; Qian W; Xiao H Mult Scler Relat Disord; 2016 Sep; 9():17-22. PubMed ID: 27645338 [TBL] [Abstract][Full Text] [Related]
2. Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO. Min JH; Waters P; Vincent A; Lee S; Y Shin H; H Lee K; Kim BJ Acta Neurol Scand; 2012 Oct; 126(4):287-91. PubMed ID: 22309305 [TBL] [Abstract][Full Text] [Related]
3. [Serum uric acid level and related clinical features in neuromyelitis optica]. You XF; Ye J; Qin W; Zhao WH; Hao YG; Hu WL Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):935-8. PubMed ID: 21211206 [TBL] [Abstract][Full Text] [Related]
4. Serum uric acid levels in patients with multiple sclerosis: a meta-analysis. Liu B; Shen Y; Xiao K; Tang Y; Cen L; Wei J Neurol Res; 2012 Mar; 34(2):163-71. PubMed ID: 22333889 [TBL] [Abstract][Full Text] [Related]
5. Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica. Peng F; Yang Y; Liu J; Jiang Y; Zhu C; Deng X; Hu X; Chen X; Zhong X Eur J Neurol; 2012 Feb; 19(2):277-83. PubMed ID: 21801283 [TBL] [Abstract][Full Text] [Related]
6. Serum uric acid levels and neuromyelitis optica. Peng F; Zhong X; Deng X; Qiu W; Wu A; Long Y; Hu X; Li Q; Jiang Y; Dai Y J Neurol; 2010 Jun; 257(6):1021-6. PubMed ID: 20094725 [TBL] [Abstract][Full Text] [Related]
7. Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica. Liu C; Xu Y; Cui L; Wang J; Peng B; Zhong L; Chen X J Clin Neurosci; 2013 Feb; 20(2):278-80. PubMed ID: 23164828 [TBL] [Abstract][Full Text] [Related]
8. Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis. Shu Y; Li R; Qiu W; Chang Y; Sun X; Fang L; Chen C; Yang Y; Lu Z; Hu X; Kermode AG Mult Scler Relat Disord; 2017 Nov; 18():65-70. PubMed ID: 29107207 [TBL] [Abstract][Full Text] [Related]
9. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica. Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736 [TBL] [Abstract][Full Text] [Related]
10. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica. Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726 [TBL] [Abstract][Full Text] [Related]
11. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252 [TBL] [Abstract][Full Text] [Related]
12. Uric acid: a potential biomarker of multiple sclerosis and of its disability. Moccia M; Lanzillo R; Palladino R; Russo C; Carotenuto A; Massarelli M; Vacca G; Vacchiano V; Nardone A; Triassi M; Morra VB Clin Chem Lab Med; 2015 Apr; 53(5):753-9. PubMed ID: 25241733 [TBL] [Abstract][Full Text] [Related]
13. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica. Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936 [TBL] [Abstract][Full Text] [Related]
14. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients. Kusumadewi W; Imran D; Witjaksono F; Pakasi TA; Rusmana AI; Pangeran D; Marwadhani SS; Maharani K; Estiasari R Mult Scler Relat Disord; 2018 Oct; 25():329-333. PubMed ID: 30195201 [TBL] [Abstract][Full Text] [Related]
15. Association between serum uric acid level and multiple system atrophy: A meta-analysis. Zhang X; Liu DS; An CY; Liu YZ; Liu XH; Zhang F; Ning LN; Li CL; Ma CM; Hu RT Clin Neurol Neurosurg; 2018 Jun; 169():16-20. PubMed ID: 29604506 [TBL] [Abstract][Full Text] [Related]
16. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis. Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373 [TBL] [Abstract][Full Text] [Related]
17. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica. Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387 [TBL] [Abstract][Full Text] [Related]
18. Serum uric acid levels in patients with Parkinson's disease: A meta-analysis. Wen M; Zhou B; Chen YH; Ma ZL; Gou Y; Zhang CL; Yu WF; Jiao L PLoS One; 2017; 12(3):e0173731. PubMed ID: 28319195 [TBL] [Abstract][Full Text] [Related]
19. Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica. Zhang B; Jiang Y; Yang Y; Peng F; Hu X Neuro Endocrinol Lett; 2008 Apr; 29(2):256-60. PubMed ID: 18404143 [TBL] [Abstract][Full Text] [Related]
20. Plasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse. Wang H; Wang K; Zhong X; Dai Y; Wu A; Li Y; Hu X J Neuroimmunol; 2012 Feb; 243(1-2):52-5. PubMed ID: 22177277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]